Zhi Tong Cai Jing·2025-11-01 17:21Core Viewpoint - Morgan Stanley reports that China Life Insurance (601628)(02628) has the highest profit growth among peers for the third quarter, with a year-to-date growth of 60.5% [1] Financial Performance - The annual Return on Equity (ROE) for the third quarter and the first nine months stands at 88.3% and 39.4% respectively [1] - The new business value for the first nine months accelerated to a growth of 41.8%, compared to 20.3% in the first half of the year [1] Market Position - China Life's performance metrics are superior to most of its competitors, indicating a strong market position [1] - The management's outlook for the company in the coming year is positive, suggesting confidence in future growth [1] Analyst Rating - Morgan Stanley sets a target price of HKD 25.7 for China Life and maintains an "Overweight" rating [1]